With the wrong architecture in place, AI algorithms can nudge biopharmaceutical developers toward unpredicted and misaligned ...

Biotech is the most honest leadership environment in the world. Science does not soften bad news. Markets do not wait for leaders to feel ready. And the pressure does not lift between a failed trial, ...

In the pharmaceutical industry, where innovation cycles span decades and billions of dollars hinge on patent protection, the relationship between a company and its external intellectual property ...

Then: Back in 2020, former Life Science Leader chief editor Rob Wright spoke with biopharma veteran Rob Perez about founding Life Science Cares, an industry philanthropic organization and platform for ...

Life sciences startups have long felt the gravitational pull of Boston and San Francisco when looking to raise capital, expand, and recruit talent. These two coastal regions, with an established ...

At a time of continuous change and increasing complexity, success for life sciences companies will largely depend on how they support, nurture and develop their teams. But even that has gotten more ...

The recipe looked perfect on paper. I'd told ChatGPT about my family's preferences for Jamaican dishes, Italian pastas, bold flavors, and it generated what seemed like ideal meal plans. The first dish ...

For many families living with rare pediatric diseases, hope often arrives quietly — after years of uncertainty, missed diagnoses, and being told that treatment may never come in time. For Lindsey ...

Marc Tessier-Lavigne, Ph.D. (left) and Martin Makary, M.D. (right) The FDA must “cut the idle time” that exists within the agency to bring drugs to market faster, said Commissioner Martin Makary, M.D.

Royalty-bearing license agreements are a cornerstone of commercialization in the life sciences and technology industries. Companies often use them to expand their business into new markets while ...

During a July episode of the Business of Biotech, Ebrahim Delpassand, M.D., founder, chairman, and CEO at RadioMedix, pointed out the importance of knowing, as a company, what you do best. It won’t be ...

As the life sciences industry grapples with the demands of AI and the need to integrate real-world evidence into increasingly complex pipelines, the FAIR data principles — Findable, Accessible, ...